2m 2m 2m 2m 2m 2m 2m
IMMUNOVANT (IMVT)
NASDAQ
$39.13+$0.51 (+1.32%)
Price as of Aug 03, 2026 8:52 AM EDT- $7.9BMarket Cap
- 145.83%1-Year Change
- BiotechnologyIndustry
IMMUNOVANT (IMVT)
$39.13+$0.51 (+1.32%)
IMVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.62 | ||
Change | -$0.86 (-2.18%) | ||
Open | $39.31 | ||
High | $39.32 | ||
Low | $38.00 | ||
Previous Close | $39.48 | ||
Volume | 668,348 | ||
30-Day Average Volume | 983,308 | ||
1-Week Change | -2.00% | ||
1-Month Change | 0.23% | ||
1-Year Change | 145.83% | ||
3-Year Change | 69.16% | ||
5-Year Change | 269.22% | ||
Fundamentals | |||
Shares Outstanding | 205.3M | ||
Total Assets | $957.0M | ||
Market Cap | $7.9B | ||
Enterprise Value | $7.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$147.9M | ||
Free Cash Flow | -$95.1M | ||
EBIT | -$150.7M | ||
EBITDA | -$150.6M | ||
Net Working Capital | $844.4M | ||
EPS | -$0.72 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 9 | ||
P/E | -53 | ||
PEG | 3 | ||
Price/Free Cash Flow | -83 | ||
Price/Operating Cash Flow | -83 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue